Advertisement

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong and Annelise Segers

Article Information

Citation 
vol. 112 no. 6 2242-2247
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 28, 2008
  • Accepted June 25, 2008
  • Published online September 8, 2008.


Contributors 
  • Harry R. Buller
  • Anthonie W. A. Lensing
  • Martin H. Prins
  • Giancarlo Agnelli
  • Alexander Cohen
  • Alexander S. Gallus
  • Frank Misselwitz
  • Gary Raskob
  • Sebastian Schellong
  • Annelise Segers

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output